MARKETSnap
  • Gainers &
    Losers
  • Most Active &
    More
  • 52-Week
    High/Low
  • P/E
    Ratios
    • Large Caps
    • Absolute
    • Total Market PE
  • Stocks
    Performance
    • Large Caps
    • Absolute
  • Industries
    Performance
    • Industry
    • Sector
  • Dividends
  • 📅 Calendar
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • 🔧 Tools
    • 💰 Intrinsic Value Calculator
    • 📈 Compounding Calculator
    • 🤖 Stock Pick Screener
  • More
    • Investment Compounding Calculator
    • Commodities
    • Currencies
    • Economic Indicators
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
CTSH stock logo

CTSH

Cognizant Technology Solutions Corporation

$38.43
-0.31
 (-0.81%)
Exchange:  NASDAQ
Market Cap:  18.209B
Shares Outstanding:  190.632M
Delayed data
Calculate CTSH Intrinsic Value
5-year outlook →
Overview
Earnings
Financials
Valuation
Chart

About The Company

Sector:  Technology
Industry:  Information Technology Services
   
CEO:  Ravi Kumar Singisetti
Full Time Employees:  336300
Address: 
300 Frank West Burr Boulevard
Teaneck
NJ
7666
US
Website:  https://www.cognizant.com
Cognizant Technology Solutions Corporation functions as a global professional services firm, delivering a comprehensive suite of consulting, technology, and outsourcing solutions across North America, Europe, and other international markets. Its operations are structured into four primary divisions: Financial Services, Healthcare, Products and Resources, and Communications, Media and Technology. Within the Financial Services sector, Cognizant provides advanced services such as enhancing customer experiences, implementing robotic process automation (RPA), and leveraging analytics and artificial intelligence (AI) to address needs in areas like digital lending, fraud prevention, and modern payment systems. For its Healthcare clients, the company focuses on navigating industry shifts toward consumer-centric models, outcome-based agreements, and digital health initiatives, striving to deliver an integrated, seamless, and patient-focused omnichannel experience. Furthermore, Cognizant assists in optimizing operations across various functions, including clinical development, pharmacovigilance, manufacturing, claims management, enrollment procedures, membership administration, and billing processes. Its clientele in this domain spans healthcare providers, payers, and life sciences organizations, encompassing pharmaceutical, biotechnology, and medical device firms. In the Products and Resources segment, the company develops solutions tailored for manufacturers, retailers, and entities within the travel and hospitality sectors, alongside those engaged in logistics, energy, and utility services. Within the Communications, Media and Technology division, Cognizant supports businesses in creating digital content, crafting personalized user experiences, and expediting digital engineering efforts. This includes serving information, media, entertainment, communications, and technology enterprises. Established in 1994, the company maintains its primary corporate office in Teaneck, New Jersey.

Click to read more…

Revenue Segmentation

MARKETSnap
MARKETSnap

Log in to continue

Log in to see the complete revenue and geographic breakdown.

Login — it's free

EPS

Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.

Log in to continue

Log in for the full EPS chart and links to analyst estimates.

Login — it's free
View full analyst estimates

Earnings Call

Full text

Earnings transcript

Read the complete earnings call transcript.

AI summary

Key takeaways

Short, structured highlights from the call so you can focus on what matters.

2026/04/29 — Q1 quarter 2026

Log in to continue

Log in to read the full transcript and AI-generated earnings summaries.

Login — it's free
Income Statement
Balance Sheet
Cash Flow Statement
Analyst Estimates

Income Statement

Year202320242025
Revenue19,353,00019,736,00021,108,000
Gross Profit6,689,0006,778,0007,117,000
EBITDA3,383,0003,534,0004,173,000
Operating Income2,689,0002,892,0003,529,000
Net Income2,126,0002,240,0002,230,000

Log in to continue

Log in to see the income statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Balance Sheet

Year202320242025
Total Assets18,483,00019,966,00020,692,000
Total Liabilities5,256,0005,558,0005,677,000
Total Stockholders Equity13,227,00014,408,00015,015,000
Total Debt1,315,0001,503,0001,575,000
Cash and Cash Equivalents2,621,0002,231,0001,901,000

Log in to continue

Log in to see the balance sheet and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Cash Flow Statement

Year202320242025
Operating Cash Flow2,330,0002,124,0002,883,000
Capital Expenditure-317,000-297,000-288,000
Free Cash Flow2,013,0001,827,0002,595,000
Net Income2,126,0002,240,0002,230,000
Net Change in Cash423,000-486,000403,000

Log in to continue

Log in to see the cash flow statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Analyst Estimates

Fiscal Year2029Research AccessResearch AccessResearch AccessResearch Access
Estimated Revenue (Low)24,491,352.173Research AccessResearch AccessResearch AccessResearch Access
Estimated Revenue (High)24,999,736.770Research AccessResearch AccessResearch AccessResearch Access
Estimated Revenue (Avg)24,739,377.871Research AccessResearch AccessResearch AccessResearch Access
Estimated Ebitda (Low)4,512,904.874Research AccessResearch AccessResearch AccessResearch Access
Estimated Ebitda (High)4,606,582.484Research AccessResearch AccessResearch AccessResearch Access
Estimated Ebitda (Avg)4,558,607.389Research AccessResearch AccessResearch AccessResearch Access
Estimated Net Income (Low)2,977,140.486Research AccessResearch AccessResearch AccessResearch Access
Estimated Net Income (High)3,057,721.246Research AccessResearch AccessResearch AccessResearch Access
Estimated Net Income (Avg)3,016,452.406Research AccessResearch AccessResearch AccessResearch Access
Estimated SGA Expense (Low)4,170,074.360Research AccessResearch AccessResearch AccessResearch Access
Estimated SGA Expense (High)4,256,635.591Research AccessResearch AccessResearch AccessResearch Access
Estimated SGA Expense (Avg)4,212,305.006Research AccessResearch AccessResearch AccessResearch Access
Estimated EPS (Avg)6.260Research AccessResearch AccessResearch AccessResearch Access
Estimated EPS (High)6.340Research AccessResearch AccessResearch AccessResearch Access
Estimated EPS (Low)6.180Research AccessResearch AccessResearch AccessResearch Access
Number of Analysts (Estimated Revenue)15Research AccessResearch AccessResearch AccessResearch Access
Number of Analysts (Estimated EPS)4Research AccessResearch AccessResearch AccessResearch Access

Log in to continue

Log in and subscribe to Full Access to see up to 5 years of analyst estimates.

Login — it's free

(* All numbers are in thousands)

Current Key Metrics

?Revenue
 (TTM)
: 
19.736B  ?P/S
 (TTM)
: 
0.89
?Net Income
 (TTM)
: 
2.24B  ?P/E
 (TTM)
: 
8.68
?Enterprise Value
 (TTM)
: 
18.557B  ?EV/FCF
 (TTM)
: 
7.51
?Dividend Yield
 (TTM)
: 
3.2%  ?Payout Ratio
 (TTM)
: 
27.55%
?ROE
 (TTM)
: 
14.79%  ?ROIC
 (TTM)
: 
12.51%
?Net Debt
 (TTM)
: 
-740000000  ?Debt/Equity
 (TTM)
: 
0.07
?P/B
 (TTM)
: 
1.27  ?Current Ratio
 (TTM)
: 
2.23

Log in to continue

Log in to see all key valuation metrics and ratios for this symbol.

Login — it's free

Forward P/E Ratios

?

Forward P/E (Avg EPS estimate) — log in with Research Access for high/low estimates and the interactive table.

Forward P/E 1YResearch AccessResearch AccessResearch AccessResearch Access
6.85Research AccessResearch AccessResearch AccessResearch Access

Log in to continue

Log in with Full Access for forward P/E high/low estimates and the full multi-year table.

Login — it's free

SWOT Analysis

🔒 You are currently logged out

Login

It's free

At what price to buy it? -
Intrinsic Value Calculator

Based on current fundamentals and analyst forecasts, MARKETSnap estimates CTSH intrinsic value between $54.09 – $68.98 per share. This depends on revenue growth, margins, and discount rate.

This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.

[intrinsic_calculator]

Common questions about CTSH valuation

Is Cognizant Technology Solutions Corporation (CTSH) overvalued or undervalued right now?

MARKETSnap estimates intrinsic value for Cognizant Technology Solutions Corporation (CTSH) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.

Is CTSH a buy, hold, or sell for long-term investors?

MARKETSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether CTSH trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.

What is CTSH’s P/E ratio?

You can see CTSH’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.

How is intrinsic value calculated for CTSH?

MARKETSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MARKETSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.

Is CTSH a good long-term investment?

Whether CTSH fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MARKETSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.

CTSH

1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.

Daily snapshot

-0.81
MARKETSnap

Trading Metrics:

Open: 38.32   Previous Close: 38.74
Day Low: 37.08   Day High: 38.76
Year Low: 37.08   Year High: 87.03
Price Avg 50: 51.18   Price Avg 200: 66.68
Volume: 4.568M   Average Volume: 9.436M

Log in to continue

Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.

Login — it's free
See in Nexus

Relevant news

New Cognizant Research Reveals $4.7 Trillion in Untapped AI Value Across G2000
15-06-2026 14:34
New Cognizant Research Reveals $4.7 Trillion in Untapped AI Value Across G2000
Cognizant's AI Builder approach to enterprise transformation earns Blueprint Pioneer Award at PegaWorld 2026
08-06-2026 14:00
Cognizant's AI Builder approach to enterprise transformation earns Blueprint Pioneer Award at PegaWorld 2026
Cognizant Technology Solutions Corporation (CTSH) Presents at Cognizant AI Forum 2026 Prepared Remarks Transcript
05-06-2026 17:22
Cognizant Technology Solutions Corporation (CTSH) Presents at Cognizant AI Forum 2026 Prepared Remarks Transcript
Cognizant Launches $500 Million Accelerated Share Repurchase
21-05-2026 06:30
Cognizant Launches $500 Million Accelerated Share Repurchase
Cognizant Technology Solutions Corporation (CTSH) Presents at J.P. Morgan 54th Annual Global Technology, Media and Communications Conference Transcript
18-05-2026 19:01
Cognizant Technology Solutions Corporation (CTSH) Presents at J.P. Morgan 54th Annual Global Technology, Media and Communications Conference Transcript
Cognizant Q1 Earnings Beat Estimates: Will Raised View Aid Shares?
30-04-2026 13:40
Cognizant Q1 Earnings Beat Estimates: Will Raised View Aid Shares?

DISCLAIMER: The stock market data provided on this website is for informational purposes only and is not intended for trading purposes. While we strive to provide accurate and timely information, we cannot guarantee that the information is accurate at the moment it is received or that it will continue to be accurate in the future. We are not responsible for any actions taken based on the information provided on this website. Always consult with a licensed financial professional before making any investment decisions.
Terms of Service

Copyright © 2025 MarketSnap. All rights reserved.

Contact Us

Privacy Policy

Cookie Policy

Terms of Service

Hover Image
MARKETSnap

Market

🇺🇸 United States

Language

  • Gainers & Losers
  • Most Active & More
  • 52-Week High/Low
  • Dividends
    • Large Caps
    • Absolute
    • Total Market PE
    • Large Caps
    • Absolute
    • Industry
    • Sector
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • 💰 Stock intrinsic value Calculator
  • 📈 Investment Compounding Calculator
  • 🤖 Stock Pick Screener
  • 📋 Watchlist & Portfolio
    • Commodities
    • Currencies
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
  • Nexus
  • Login Login
  • Profile Profile
  • Watchlist & Portfolio Watchlist & Portfolio
  • My Valuations My Valuations
  • Settings Settings

Media

Watch Listen Read